| Literature DB >> 12836668 |
Abstract
Structural genomics is poised to have a tremendous impact on traditional structure-based drug design programs. As a result, there is a growing need to obtain rapid structural information in a reliable form that is amenable to rational drug design. In this manner, NMR has been expanding and evolving its role in aiding the design process. A variety of NMR methodologies that cover a range of inherent resolution are described in the context of structure-based drug design in the era of structural genomics.Mesh:
Substances:
Year: 2002 PMID: 12836668 DOI: 10.1023/a:1020445506369
Source DB: PubMed Journal: J Struct Funct Genomics ISSN: 1345-711X